Huang group and Nakano group recently reported that FoxM1 knockdown sensitized GBM cells to TMZ chemotherapy mainly through Rad51 downregulation [18] and interference of MELK-mediated signaling, respectively. Here, FOXM1 is linked to glioblastoma.